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Abstract: Proteins derived from the natural extracellular matrix like collagen or gelatin are common
in clinical research, where they are prized for their biocompatibility and bioactivity. Cells are able
to adhere, grow and remodel scaffolds based on these materials. Usually, collagen and gelatin
are sourced from animal material, risking pathogenic transmission and inconsistent batch-to-batch
product quality. A recombinant production in yeast circumvents these disadvantages by ensuring
production with a reproducible quality in animal-component-free media. A gelatin mimetic protein,
based on the alpha chain of human collagen I, was cloned in Pichia pastoris under the control of
the methanol-inducible alcohol oxidase (AOX1) promoter. A producing clone was selected and
cultivated at the 30 L scale. The protein was secreted into the cultivation medium and the final yield
was 3.4 g·L−1. Purification of the target was performed directly from the cell-free medium by size
exclusion chromatography. The gelatin mimetic protein was tested in cell culture for biocompatibility
and for promoting cell adhesion. It supported cell growth and its performance was indistinguishable
from animal-derived gelatin. The gelatin-mimetic protein represents a swift strategy to produce
recombinant and human-based extracellular matrix proteins for various biomedical applications.
Keywords: gelatin-mimetic protein; recombinant gelatin; Komagataella pfaffi (Pichia pastoris);
recombinant ECM-protein
1. Introduction
Collagen and its denatured derivatives, such as gelatin, are used for many biomedical applications
including wound dressings, graft coatings, suture material, drug release, and tissue engineering [1–3].
These materials, despite their wide use, possess several disadvantages associated with their origin and
method of production. Collagen and its derivatives are sourced from animal tissue, which brings the
risk of allergic reactions, as well as the transmission of pathogens like viruses and prions. The age
and physiological state of the tissue of origin brings further variability to the final collagen product.
Gelatin is produced from denatured collagen by acidic or alkaline extraction [4]. This commercial
process delivers wide variation in batch-to-batch product quality, which can represent a challenge for
medical applications [5].
The production of recombinant collagen-based materials allows the circumvention of the
above-mentioned drawbacks associated with animal-derived materials. Therefore, many groups
have aimed to produce recombinant collagen-based materials in various organisms. Recombinant
collagen I has already been produced in transgenic mice, tobacco plants, silk worms, insect cell
lines, and mammalian cell lines [5]. A production in simple microorganisms like yeast and bacteria
would make a recombinant collagen mimetic protein more attractive in terms of achievable yields and
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production costs [6]. However, the complexity of helical collagens makes it challenging to integrate
them into a microbial recombinant system [7].
Type I collagen, the most commonly used collagen type in biomedical applications, is a heterotrimer
consisting of two alpha 1 and one alpha 2 chains. The central helical domain of this molecule consists
of repetitive Gly-Xaa-Yaa sequences, with Xaa and Yaa being proline and hydroxyproline respectively.
The thermal stability of collagen is dependent on the hydroxylation of proline with the enzyme
prolyl-4-hydroxylase (P4H), which is present in sufficient amounts only in mammalian cell expression
systems. In order to produce correctly-folded collagen in most expression systems like plants, insect
cells, bacteria, and yeasts, it is therefore necessary to also clone both subunits of the P4H enzyme.
The group of Myllyharju accomplished the successful cloning, production and expression of human
collagen types I, II and III in the yeast Pichia pastoris (P. pastoris) [8]. To achieve this, the enzyme P4H
was also cloned into the yeast strains. The authors could show that the recombinant collagens are
triple-helical, but as a result, cannot be exported from the yeast cell [9]. The recombinant collagen from
P. pastoris has been successfully commercialized [10].
In this study, we aimed to produce a recombinant collagen fragment which can be secreted from
the cell into the media and be produced in simple microorganisms using animal component-free media.
Also, we wanted to circumvent the production of P4H and the cloning of its associated subunits,
but still obtain a gelling product. The cloning of collagen fragments into Escherichia coli (E. coli) or yeast
without P4H results in the production of random-coiled collagens, which resemble gelatin in their
structure. Therefore, in this work we present the production of a non-hydroxylated gelatin-mimetic
protein (GelMP) in P. pastoris. We selected this yeast, as it is known that yeasts are able to convert
repetitive genes better than E. coli and because we were aiming for extracellular production [11]. Our
goal was to design a cost-efficient, simple and quick process starting from the cloning procedure to the
final purification of the material. In order to simplify the process, we cloned a single gene coding for a
400 amino acid segment from the helical region of the human collagen I alpha1 chain and included
repetitive prolyl-glycyl-prolyl (PGP)-sequences flanking on both sides of the collagen sequence. Such
artificial repeats are inspired by the Gly-Xaa-Yaa structure of collagen and are known to possess thermal
trimerization capacity under specific circumstances [12]. The group of Werten et al. demonstrated
that gels from these telechelic triblock (ABA) protein polymers are formed on long incubation times at
appropriate concentrations, in accordance with studies performed on synthetic (Pro-Gly-Pro)9 peptides
(PGP) [13]. In our study, we combined a sequence from the helical region of collagen I to introduce
bioactivity and PGP repeats to incorporate gelling behavior without hydroxylation by P4H.
2. Results and Discussion
2.1. Production of GelMP
A 1.9 kb fragment, encoding the 40.7 kDa GelMP, was cloned into the P. pastoris expression vector
pPIC9K. The vector thus obtained was used to transform P. pastoris GS115. Successful vector integration
was confirmed using colony PCR (data not shown). Several Mut+ transformants were randomly
chosen and tested for GelMP production in shaking flasks by methanol induction. A representative
GelMP transformant was selected for fermentation experiments. Culture supernatants harvested
throughout the fermentation were analyzed with SDS-PAGE (Figure 1A).
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Figure 1. (A) SDS-PAGE of cultivation supernatant samples, 1: glycerol phase before induction at 48 
h of cultivation; 2: Induction with methanol t = 71 h; 3: 72 h; 4: 78 h; 5: 80 h. M: Marker Precision Plus 
Protein™ Unstained Protein Standard. (B) Western blot of supernatant, N: negative control; P: human 
collagen I as a positive control; M: Prestained protein ladder, 0-71 = cultivation hours; in this 
cultivation methanol induction was performed earlier at t = 29 h. GelMP can be observed 1 h after 
induction at t = 30 h. 
After 1 h of induction with methanol the target protein can be observed at 75 kDa (Figure 1A, 
lane 3). SDS-PAGE analysis of intracellular fractions of the cultivation revealed that GelMP does not 
accumulate inside the cell (please see Supplementary Material, Figure S1). The identity of the secreted 
protein was confirmed by both Western blot (Figure 1B) and mass spectrometry (data not shown). 
The observed molecular weight of ca. 75 kDa in the gel electrophoresis is higher than the theoretical 
molecular weight of 40.7 kDa. It has already been widely described in the literature that collagen-like 
proteins and synthetic gelatins migrate at an apparent molecular weight one to four times higher 
than their true molecular weight in SDS-PAGE gels [14,15]. An additional explanation for the higher 
observed molecular weight might be glycosylation of the protein. This hypothesis was tested with a 
PNGase F assay and was found to be negative (data not shown). Furthermore, mass spectrometry 
analysis did not reveal any glycosylation as well, leading to the conclusion that the protein is truly 
40.7 kDa, but appears larger due to erratic behavior in SDS-PAGE. 
Apart from the full-length band at 75 kDa, another band of lower molecular weight (ca. 65 kDa) 
was also observed. Both bands were analyzed by N-terminal sequencing and proven to be fragments 
of the major GelMP protein. Edman sequencing showed that band (a) in Figure 1 is the expected 
amino acid sequence of the GelMP protein (YVEFPGPPGP), while band (b) corresponds to a lesser 
fragment of the GelMP protein starting with (GFPGPKGAAG). The smaller GelMP fragment is most 
likely produced by proteolytic degradation. Indeed, the random-coil structure of unhydroxylated 
collagens makes them very susceptible to proteolytic degradation [11]. Cultivations strategies for 
reducing proteolysis like the addition of casamino acids to the culture medium or lower pH values 
were also tried in efforts to suppress the production of the smaller fragment, but without success [16]. 
The proteolytic degradation occurs probably already inside the cell. Another strategy for preventing 
proteolytic degradation would include changing the expression host to a protease deficient strain like 
SMD1168 or a change in the amino acid sequence of GelMP, making the protein immune to 
intracellular proteolytic degradation. 
2.2. Purification of the GelMP Protein 
After cultivation completion, the biomass was removed by centrifugation and the medium 
containing the secreted protein was processed by chromatography. GelMP was purified directly from 
the fermentation broth using size exclusion chromatography (SEC). Single-step purification of GelMP 
with SEC was selected due to there being only a small amount of impurities besides the target protein 
and its major degradation fragment in the fermentation supernatant (Figure 1). The elution of the 
SEC is shown in Figure 2A. The target fraction with GelMP can be found in the first peak (1). The 
second peak (2) contains only culture residues and salts (Figure 2B, lane 3). This is also indicated by 
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After 1 h of induction with methanol the target protein can be observed at 75 kDa (Figure 1A,
lane 3). SDS-PAGE analysis of intracellular fractions of the cultivation revealed that GelMP does not
accumulate inside the cell (please see Supplementary Material, Figure S1). The identity of the secreted
protein was confirmed by both Western blot (Figure 1B) and mass spectrometry (data not shown).
The observed molecular weight of ca. 75 kDa in the gel electrophoresis is higher than the theoretical
molecular weight of 40.7 kDa. It has already been widely described in the literature that collagen-like
proteins and synthetic gelatins migrate at an apparent molecular weight one to four times higher
than their true molecular weight in SDS-PAGE gels [14,15]. An additional explanation for the higher
observed molecular weight might be glycosylation of the protein. This hypothesis was tested with a
PNGase F assay and was found to be negative (data not shown). Furthermore, mass spectrometry
analysis did not reveal any glycosylation as well, leading to the conclusion that the protein is truly
40.7 kDa, but appears larger due to erratic behavior in SDS-PAGE.
Apart from the full-length band at 75 kDa, another band of lower molecular weight (ca. 65 kDa)
was also observed. Both bands were analyzed by N-terminal sequencing and proven to be fragments
of the major GelMP protein. Edman sequencing showed that band (a) in Figure 1 is the expected
amino acid sequence of the GelMP protein (YVEFPGPPGP), while band (b) corresponds to a lesser
fragment of the GelMP protein starting with (GFPGPKGAAG). The smaller GelMP fragment is most
likely produced by proteolytic degradation. Indeed, the random-coil structure of unhydroxylated
collagens makes them very susceptible to proteolytic degradation [11]. Cultivations strategies for
reducing proteolysis like the addition of casamino acids to the culture medium or lower pH values
were also tried in efforts to suppress the production of the smaller fragment, but without success [16].
The proteolytic degradation occurs probably already inside the cell. Another strategy for preventing
proteolytic degradation would include changing the expression host to a protease deficient strain like
SMD1168 or a change in the amino acid sequence of GelMP, making the protein immune to intracellular
proteolytic degradation.
2.2. Purification of the GelMP Protein
After cultivation completion, the biomass was removed by centrifugation and the medium
containing the secreted protein was processed by chromatography. GelMP was purified directly from
the fermentation broth using size exclusion chromatography (SEC). Single-step purification of GelMP
with SEC was selected due to there being only a small amount of impurities besides the target protein
and its major degradation fragment in the fermentation supernatant (Figure 1). The elution of the SEC
is shown in Figure 2A. The target fraction with GelMP can be found in the first peak (1). The second
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peak (2) contains only culture residues and salts (Figure 2B, lane 3). This is also indicated by the increase
in conductivity (Figure 2B). It was not possible to achieve separation between the GelMP protein and
its major fragment, so that both proteins were isolated in the same fraction. Downstream efforts to
separate the two fragments by fractional precipitation or alternative chromatographic methods did not
lead to the desired outcome either. The two proteins possess only a small difference in molecular mass
(40.7 kDa to 34.2 kDa) and have highly identical properties making chromatographic separation very
challenging. However, since the GelMP fragment does not impair the functionality of the protein as a
gelatin mimetic, both proteins were purified together and used for cell culture experimentation. All
yield values are thus based on the product GelMP and its major fragment.
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this characteristic spectrum at any temperature tested (Figure 3B). The PGP repeats and the non-
hydroxylated collagen middle block result in random coil configuration of the protein. Similar 
findings were obtained by Werten et al., who designed a triblock design protein based on PGP repeats 
and a random middle block, which also did not display positive ellipticity in the λ = 215 − 240 nm 
region [12]. Collagen-mimetics based on PGP-repeats can form triple helices at low temperatures and 
prolonged incubation times. This propensity is greatly increased if stabilizing features like a foldon 
domain [13] or a mimetic cystine knot [17] are introduced into the protein design. 
Figure 2. (A) SEC using a Sephadex G-25 column (flow rate: 5 mL min−1; sample volume: 15 mL).
Buffer exchange to phosphate-buffered saline buffer (PBS). 1: Elution peak of GelMP. (B) SDS-PAGE
analysis of GelMP protein purification (SEC). M: Marker Precision Plus Protein™ Unstained Protein
Standards, lane 1: supernatant broth; lane 2: protein after SEC; lane 3: salt peak (2) from Figure 2A.
The endotoxin value of the isolated product is a critical parameter for biomedical applications.
After the SEC, a polishing step using membrane anion-exchange chromatography was introduced,
in order to remove any ndotoxins pr sent in the material. After this treatm nt, the endotoxin v lue
was 1.2 EU/mg. Further reduction t this value can be achieved by using pyrogen-free glassware and
e otoxin-fr e water in all process steps.
2.3. Structural Characterization
CD spectra wer record d for GelMP, human collagen I, heat-denatur d collage , and gelatin.
Only human collagen I showed positive ellipticity at λ = 225 nm and a m imum below 200 ,
ind cating the presence of a triple helical conformatio (Figure 3A). As expected, GelMP did not
sh w this characteristic spectrum at any temperature tested (Figure 3B). The PGP r peats and the
n n-hydroxylated collagen m ddle block result in random coil configuration of the protein. Similar
findings were obtained by Werten et al., who designed a triblock design protein based on PGP repeats
and a random middle block, which also did not display positive ellipticity in the λ = 215 − 240 nm
region [12]. Collagen-mimetics based on PGP-repeats can form triple helices at low temperatures and
prolonged incubation times. This propensity is greatly increased if stabilizing features like a foldon
domain [13] or a mimetic cystine knot [17] are introduced into the protein design.
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Figure 3. (A) Circular dichroism spectra of human collagen I, denatured collagen I and recombinant
GelMP. (B) Circular dichroism spectra of recombinant GelMP (10–60 ◦C), gelatin A and human collagen
I. Far ultraviolet (190–240 nm) CD spectra were recorded at a concentration of 1 mg·mL−1 for all proteins.
The recombinant GelMP behaves like a gelatin mimetic by forming a weak gel on prolonged
incubation at temperatures below 37 ◦C (Figure 4A). The storage modulus was higher than the loss
modulus from the start of incubation, indicating the formation of a viscoelastic solid. As a next step,
the effect of buffer composition on protein stability was investigated using nano-differential scanning
fluorimetry (Figure 4B). The highest apparent melting temperature was observed in PBS buffer at
pH 7.4 (Tm = 69 ◦C).
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Figure 4. (A) Storage (G’) and loss (G”) moduli for a 2.5 mM GelMP solution. Gel formation was
analyzed with a time-sweep experiment (frequency (f) = 1 Hz and strain (γ) = 0.1%). (B) Thermal
denaturation of GelMP, determined by differential scanning fluorimetry.
The observed apparent melting temperature is higher than the one (Tm = 42 ◦C) reported for
triblock protein polymers with (PGP)9 r peats, of similar molecular size a d using differential scanning
calorimetry (DSC) [12]. However, care must be taken when co paring the values, a it is not always
possible to di ectly compare between DSC and differenti l scanning fluorimetry (DSF) tran ition
temperatures. Here, ad itional factors such as the ther l scan rat should be conside ed [18].
2.4. Biocompatibility and Functionality of GelMP/Caspase Apoptosis Assay
In ord r to study the potential of GelMP in replacing mammali n derivatives, it was important to
investigate its non-toxicity and biocompatibility. hAD-MSCs were cultured with GelMP, gelatin and
bovine serum albumin (BSA) at the same concentration in an IncuCyte® Live-Cell Analysis System.
J. Funct. Biomater. 2019, 10, 39 6 of 12
The kinetic monitoring of cytotoxicity and apoptosis of the cells was performed in the presence of
the Caspase 3/7 Apoptosis Assay Reagent. Images were collected every 2 h. After a 60 h incubation
period, images and quantification of apoptosis (green object count/image) showed that GelMP, gelatin
and BSA-treated cells (Figure 5B) are all similar to each other and display no toxicity to hAD-MSCs.
The recombinant GelMP functions as a typical natural extracellular matrix protein-component (ECM)
and is non-toxic to cells.
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Figure 5. (A) Real-time cell confluence study in a hAD-MSCs cell line, media was treated with different
additives (GelMP, bovine serum albumin (BSA), gelatin A and no addition (X) as a control). (B) The
number of caspase-3/7 positive cells was recorded over time and plotted as fluorescence objects, n = 3
wells per data point shown; X = control.
Adhesion to the extracellular matrix or to other cells is essential for the growth, communication
and survival of mammalian cells [19]. For the adhesion assay, the attachment and proliferation of
hAD-MSCs to different cell culture coatings was monitored in real-time using the IncuCyte® microscope.
As shown in Figure 6, GelMP increased cell confluence in comparison to cell growth on the BSA
substrate or plastic cell culture surface alone. By the end of the 20 h culture period, the hAD-MSC
cultures in wells coated with GelMP or gelatin demonstrated level of confluence almost double the
one exhibited by cultures growing on uncoated surfaces. Gelatin and GelMP show a standard growth
curve with up to 100% cell confluence level by 60 h, while cultures growing on the uncoated and
BSA-coated wells reach 45% cell confluence (Figure 6A). In addition, MSCs growing on GelMP and
gelatin displayed similar elongated and spindle-like morphology (Figure 6C). In addition, hAD-MSCs
growing on BSA and uncoated surfaces could not adhere efficiently to the surface and tended to form
agglomerates (Figure 6B). The biofunctionality experiments demonstrated that the recombinant GelMP
is non-toxic and biocompatible and its performance is indistinguishable to that of animal-derived
materials like gelatin.
J. Funct. Biomater. 2019, 10, 39 7 of 12
J. Funct. Biomater. 2019, 10, x FOR PEER REVIEW 7 of 12 
 
 
Figure 6. (A) Real-time cell confluence study in a hAD-MSCs cell line; growth on four different 
surfaces (GelMP, gelatin, BSA and X = uncoated surface). The cell population was monitored for 60 h 
using the IncuCyte® system in an incubator (5% CO2 and 37 °C). (B) Agglomerate formation on 
different surfaces. (C) Cell morphology on GelMP, gelatin, BSA and X = uncoated surfaces at 0, 20, 48, 
and 60 h. Scale bar 500 µm. Videos of the cell growth and adhesion process can be found in the 
supplementary section of the journal and are also linked as a QR-Code. 
3. Materials and Methods 
3.1. Vector Construction 
Figure 6. (A) Real-time cell confluence study in a hAD-MSCs cell line; growth on four different surfaces
(GelMP, gelatin, BSA and X = uncoated surface). The cell population was monitored for 60 h using
the IncuCyte® system in an incubator (5% CO2 and 37 ◦C). (B) Agglomerate formation on different
surfaces. (C) Cell morphology on GelMP, gelatin, BSA and X = uncoated surfaces at 0, 20, 48, and 60 h.
Scale bar 500 µm. Videos of the cell growth and adhesion process can be found in the supplementary
section of the journal and are also linked as a QR-Code.
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3. Materials and Methods
3.1. Vector Construction
The recombinant GelMP consists of two segments: a 400 amino acid sequence sourced from the
alpha chain of type I human collagen (amino acid sequence 541 to 940), and (Pro-Gly-Pro)9 (PGP) repeats
flanking this sequence on each side (Figure 7). Cleavage sites for SpeI and PacI were inserted between
the collagen sequence and the PGP repeats. In addition, an EcoRI and NotI site were inserted at the 5′
and 3′-ends, respectively. The GelMP designed in this manner was codon-optimized and produced by
a gene synthesis service (Thermo Fischer, Waltham, MA, USA). The synthetic gene was delivered in a
pMK-RQ vector construct. Utilizing the added restrictions sites EcoRI and NotI, the construct was
cloned in frame into the cloning/expression region of pPIC9K (InvitrogenTM, Carslbad, CA, USA).
The sequence was verified by automated DNA sequencing (Eurofins Genomics, Ebersberg, Germany).
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3.2. Organism and Transformation
The expression vector pPIC9K-GelMP was linearized with SalI and used to transform competent
GS115 (his4) cells according to the protocol of Lin-Cereghino [20]. Transformants were spread on
minimal dextrose plates and incubated for 72 h at 30 ◦C. Clones were screened using colony PCR and
potential Mut+ transformants were identified. Recombinants were then tested for multiple insertion
of the gene-of-interest on geneticin-containing yeast extract–peptone–dextrose plates (range of G418:
0.5 to 4 mg·mL−1). Selected clones growing on the 4 mg mL−1 G418 plate were screened for protein
expression in shake flasks as described by ref. [21]. The highest producer was selected for further work
and transferred to a bioreactor for scale up of production.
3.3. Fermentative Production of GelMP in P. pastoris
A 30 L stainless steel bench top bioreactor (Biostat® Cplus, Sartorius, Göttingen, Germany) was
equipped with a di solved oxygen electrode (InPro6820, Mettler-T ledo, Columbus, OH, USA), a
pH-electrode (EasyFerm Plus K8 200, Hamilton, Martinsried, Germany), a methanol sensor system
(Raven Bio-Tech Inc., Canada), and a peristaltic pump (Ismatec Reglo ICC, Wertheim Germany). A
Biostat® Cplus co trol unit (Sartorius, Göttingen, Germany) was c nnected to the bioreactor for
fermentation control. The meth nol sensor system was connected to a single-board computer for data
processing. Bioreactor op ration data was logged using ProfiSignal (Delphin Technology, Germany). A
1 mL aliquot of a cry culture (OD600 = 50) was thawed and placed in 100 mL medium (per liter: 25 g
(NaPO3)6, 0.93 g C SO4, 18.2 g K2SO4, 14.9 g MgSO4·7H2O, 9 g (NH4)2SO4, 40 g glycerol and 0.435%
PTM1 (per liter: 6 g CuSO4·5H2O, 0.08 g NaI, 3 g MnSO4·H2O, 0.2 g Na2MoO4·2H2O, 0.02 g H3BO3,
0.5 g CoCl2, 20 g Zn l2, 65 g FeSO4·7H2O, 0.2 g Biotin, 5 mL H2SO4). The pre-culture was cultivated
until the cells reached OD600 = 10–15. The bioreactor was filled with 10 L fermentation medium (per
lit r: 25 g (NaPO3)6, 0.93 g CaSO4, 18.2 g K2SO4, 14.9 g MgSO4·7H2O, 9 g (NH4)2SO4, 120 g glycerol
and 0.435% PTM1) and was inoculated with cells from the pre-culture to an OD600 = 0.1. The operation
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parameters were pH 5.0, 30 ◦C, dissolved oxygen (DO) level of 30% air saturation and a gas flow rate of
2 L·min−1. The DO level was controlled using the stirrer cascade system of the BIOSTAT® Cplus and
by supplying pure oxygen if necessary. After depletion of glycerol, the methanol feed (100% methanol
with 12 mL·L−1 PTM1) was set up to 0.2% v/v methanol. The cultivation ended after 80 h.
3.4. Purification of GelMP from the P. pastoris Culture Supernatant
The supernatant was harvested after 80 h of cultivation by centrifugation (5000× g, 30 min, 4 ◦C)
and stored at −20 ◦C until further processing. GelMP was purified directly from the fermentation
broth using an ÄKTA Pure system (GE Healthcare, Chicago, IL, USA). Then 15 mL of supernatant was
loaded on a Sephadex G-25 column (HiPrep™ 26/10 Desalting, GE Healthcare) previously equilibrated
with PBS puffer (pH 7.4). GelMP protein was eluted with PBS buffer at a flow rate of 5 mL min−1 for
40 min monitoring UV-absorption and conductivity. The peaks eluted from the column were analyzed
by 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). Fractions of 8 mL
were collected and pooled for lyophilization.
A polishing step for the removal of potential endotoxins was also introduced. The target protein
was dissolved in Tris-HCl (pH 7.5, 20 mM) to a concentration of 1 mg/mL and was passed through
an anion exchange membrane in a flow-through mode (Sartobind® pico, membrane area: 2.9 cm−2,
membrane volume: 0.08 mL, Sartorius, Göttingen, Germany). The endotoxin concentration after the
polishing step was measured with an Endosafe® nexgen-PTS™ system (Charles River, Wilmington,
MA, USA).
3.5. Bicinchoninic Acid Protein Assay
For the determination of protein concentration, a bicinchoninic acid (BCA) assay (Pierce BCA
Protein Assay Kit, Thermo Fisher Scientific, Waltham, MA, USA) was performed. Native collagen I
from human placenta (Santa Cruz Biotech., Dallas, TX, USA) was used as a reference.
3.6. SDS PAGE and Western Blot Analysis
Protein samples were analyzed with SDS-PAGE using 10% Tris-HCl gels and a Mini Protean Tetra
Cell System (BioRad, USA). The culture supernatant was mixed 1:1 with Laemmli buffer (2×) and
10 µL were loaded onto the gel. A Precision Plus Protein Standard (BioRad, Hercules, CA, USA) was
used for the determination of molecular weight. Proteins were visualized with Coomassie Brilliant
Blue G 250 staining. SDS-PAGE protein bands were blotted onto a PVDF membrane [22], which was
then subjected to Western blot analysis using the Western Breeze Immunodetection Kit (Invitrogen,
USA) according to the manufacturer’s instructions and using a collagen-I-antibody (Acris Antibodies,
Nr. R1038, Herford, Germany). N-terminal sequencing was performed in the Helmholtz Zentrum
(HZI) Braunschweig.
3.7. Circular Dichroism Spectroscopy
Circular dichroism (CD)-spectra were recorded using a spectropolarimeter J-815 (Jasco, Pfungstadt,
Germany). The purified GelMP and gelatin A (Sigma Aldrich, St. Louis, MO, USA) were dissolved
in PBS buffer at a concentration of 1 mg/mL. The human collagen I (Biotechnology Inc., USA) was
dissolved in acetic acid (1 mg/mL) and was also treated at 90 ◦C for 10 min for thermal denaturation.
Test solutions were placed in a cuvette with a 1 mm path length and spectra were recorded in the
190–240 nm region. The spectra were obtained with a scanning speed of 50 nm/min at a resolution of
0.5 nm. Melting curves from 10 to 60 ◦C were derived by increasing the temperature in steps of 10 ◦C.
Measurements were performed 5 times and the averaged scan values were plotted.
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3.8. Label-Free Differential Scanning Fluorimetry
Thermostability was measured by nano differential scanning fluorimetry (DSF) on a Tycho NT
6 instrument (NanoTemper Technologies, Munich, Germany) with a back-reflection aggregation
detection at a range from 20–95 ◦C and with a heating rate of 30 ◦C/min. Protein unfolding was
followed by tryptophan/tyrosine fluorescence intensity at 330 and 350 nm in various buffers covering
pH 5–8.5. The apparent melting temperature (Tm) was determined by detecting the maximum
of the first derivative of the fluorescence ratios (F350/F330) after fitting experimental data with a
polynomial function.
3.9. Rheological Characterization
The gel formation of a 2.5 mM GelMP solution in PBS (pH = 7.4) was investigated at 15 ◦C using a
MCR 302 Modular Rheometer, Anton Paar, Austria) equipped with a plate-plate geometry (20 mm
diameter, 1 mm gap size). The trimerization was recorded with a time sweep oscillatory test under
constant strain amplitude of 0.1% and at a constant frequency of 1 Hz for a period of 20 h. A solvent
trap was used to prevent sample loss by evaporation.
3.10. Cell Culture and Proliferation
Cell proliferation on GelMP coatings was assessed by using a culture of human adipose-derived
mesenchymal stem cells (hAD-MSC). hAD-MSCs were expanded in alpha-MEM medium (Thermo
Fisher Scientific, Braunschweig, Germany) containing 1 g L−1 glucose, 2 mM L-glutamine, 10% human
serum (CC-pro, Oberdorla, Germany) and 50 µg·mL−1 gentamicin (Biochrom, Berlin, Germany),
harvested by accutase treatment (Sigma Aldrich, St. Louis, MO, USA). Experiments were performed
with hAD-MSCs of passages two to twelve.
3.11. Cell Adhesion Experiments
The lyophilized GelMP was dissolved in PBS-buffer (pH 7.4) at a concentration of 2 mg mL−1.
Then 400 µL of this GelMP solution was added in each well and incubated at 4 ◦C for 12 h to allow
protein adsorption to the well surfaces. Next, wells were rinsed with several milliliters of PBS buffer to
remove excess protein. As control for the adhesion experiment, a set of wells were coated with bovine
serum albumin (BSA) and gelatin (Sigma Aldrich, gelatin type A, St. Louis, MO, USA) with the same
concentration and using the same procedure as for GelMP.
For adhesion experiments, hAD-MSCs were seeded onto a coated 48-well-plate (Eppendorf,
Germany) at a density of 15,000 cells/cm2 with 300 µL medium per well. After seeding, cells were
cultivated for 60 h in alpha-MEM containing 10% fetal bovine serum (FBS) and 50 µg mL−1 gentamicin
in a humidified atmosphere containing 5% CO2 and 21% O2 at 37 ◦C. During the cultivation, microscopic
pictures were taken every 2 h (four fields imaged per well) using an IncuCyte® Live-Cell Imaging
System (Sartorius, Göttingen, Germany). Data were analyzed using the IncuCyte® Confluence software
(IncuCyte® S3 2018 A), which quantified cell surface area coverage as confluence values.
3.12. Biocompatibility of GelMP by a Quantitative Assay of Caspase-3/7 Kinetic Activation
The hAD-MSCs were seeded in 48 well-plates at a density of 15,000 cells/well in 300 µL culture
medium (alpha-MEM containing 10% FBS, 50 µg mL−1 gentamicin, and 0.5 µM IncuCyte® Caspase-3/7
reagent). The medium was previously mixed with GelMP, gelatin and BSA, resulting in a final
concentration of 5 mg·mL−1. A quantitative analysis of apoptosis of hAD-MSCs over time was
performed during the cultivation in treated medium (GelMP, BSA, gelatin) and with regular cell culture
medium serving as a control. Once treated, the cells were immediately placed inside the IncuCyte®
Live-Cell Analysis System (Sartorius Stedim Biotech GmbH, Göttingen, Germany) with a 10× objective
in a standard cell culture incubator and both phase-contrast and fluorescent images were collected
every 2 h.
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4. Conclusions
Large-scale production of a recombinant non-hydroxylated gelatin mimetic protein was achieved
by methanol-fed cultivation of P. pastoris. This yeast is a suitable host for the high-level production of
recombinant gelatins. These proteins serve as recombinant extracellular matrix constituents and possess
excellent biocompatibility, without risks of pathogenic transmission associated with animal-derived
products. The target protein GelMP was produced routinely at levels of >3 g·L−1, which is comparable
to other recombinant protein production efforts in this yeast. The GelMP was secreted into the
media from which it could be directly isolated by SEC. The protein serves as an excellent substrate
in cell culture and can support cell attachment and spreading in a manner non distinguishable
from animal-derivatives.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4983/10/3/39/s1,
Video S1: X. Video S2: GelMP, Video S3: BSA, Video S4: gelatin A, FigureS1: Western Blot of pellet.
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